Skip to content
Adam Torkildson – Lifestyle
Author:
MMJ International Holdings
MMJ Federal Challenges Put Trump Administration’s Marijuana Rescheduling Shortcut at Risk
August 17, 2026
Something Is Rotten at CMS: Dr. Oz Demands FDA Approval – Then Defends a $500 Medicare Pathway for Unapproved Hemp Products
August 17, 2026
MMJ Challenges Washington’s “No Product” Cannabinoid Narrative as Dr. Oz Endorses Unvalidated CMS Hemp Products
August 12, 2026
Dr. Oz’s Push to Expand Medicare CBD Access After European Regulators Could Not Establish Safety of Charlotte’s Web Hemp Extract
August 12, 2026
Marijuana Industry Is Drowning In Confusion: Why Is Industry Now Demanding Hemp Standards It Never Applied to Itself
August 5, 2026
MMJ ET AL PREPARES APPEAL CMS HEMP PROGRAM: How Can a Company With a Manufactured Pharmaceutical Soft Gel Be Told It Has “No Product”?
June 1, 2026
CMS Hemp Program Insiders Admit Bypassing FDA Safety Standards for a Potential $34.5 Billion Medicare Payday
May 15, 2026
CMS Hemp Program Insiders Admit Bypassing FDA Safety Standards for a Potential $34.5 Billion Medicare Payday
May 15, 2026
Candy-Coated Costs: How Unvalidated Hemp Gummies Found a Back Door Into Medicare
May 11, 2026
MMJ International Holdings Seeks Federal Preliminary Injunction May 1 to Halt CMS Hemp-CBD Medicare Pilot
April 19, 2026
1
2
Next Page
→